Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,380 | 3,075 | 56,376 | 16,787 | 2,639 |
| Cost of Goods | 50 | 52 | 59 | 798 | 38 |
| Gross Profit | 2,330 | 3,023 | 56,317 | 15,989 | 2,601 |
| Operating Expenses | 233,684 | 161,705 | 136,457 | 155,803 | 189,371 |
| Operating Income | -231,304 | -158,630 | -80,081 | -139,016 | -186,732 |
| Other Income | 17,764 | 18,740 | 15,081 | 18,259 | 20,106 |
| Pre-tax Income | -213,540 | -139,890 | -65,000 | -120,757 | -166,626 |
| Income Tax | 177 | -1,512 | 276 | -4,784 | -3,213 |
| Net Income Continuous | -213,717 | -138,378 | -65,276 | -115,973 | -163,413 |
| Net Income | $-213,717 | $-138,378 | $-65,276 | $-115,973 | $-163,413 |
| EPS Basic Total Ops | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 |
| EPS Basic Continuous Ops | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 |
| EPS Diluted Total Ops | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 |
| EPS Diluted Continuous Ops | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 |
| EPS Diluted Before Non-Recurring Items | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 |
| EBITDA(a) | $-228,054 | $-151,733 | $-75,326 | $-133,186 | $-179,837 |